Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06489158 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade

StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 20, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date: Oct 1, 2024 to Sep 9, 2024 · Study description expanded, about 167 wordsv3 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Start date: Oct 1, 2024 to Sep 9, 2024
    • Study description expanded, about 167 words

    See this version in full on ClinicalTrials.gov ↗

  3. Start date: Jul 1, 2024 to Oct 1, 2024 Primary completion date: Sep 1, 2024 to Dec 31, 2024 · Completion date: Jul 1, 2025 to Dec 31, 2025v2 Show 2 more changesShow less
    • Primary completion date: Sep 1, 2024 to Dec 31, 2024
    • Completion date: Jul 1, 2025 to Dec 31, 2025
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
1. Explore VOCs indicators that can effectively distinguish between benign and malignant breast diseases. 2. The accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in determining benign and malignant diseases based on pathological gold standards.
Trial Details
NCT Number NCT06489158
Lead Sponsor Peking Union Medical College Hospital
Conditions Breast Cancer
Enrollment 168 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov